287 related articles for article (PubMed ID: 12399289)
1. Safety and pharmacokinetics of purified soy isoflavones: single-dose administration to postmenopausal women.
Bloedon LT; Jeffcoat AR; Lopaczynski W; Schell MJ; Black TM; Dix KJ; Thomas BF; Albright C; Busby MG; Crowell JA; Zeisel SH
Am J Clin Nutr; 2002 Nov; 76(5):1126-37. PubMed ID: 12399289
[TBL] [Abstract][Full Text] [Related]
2. Clinical characteristics and pharmacokinetics of purified soy isoflavones: single-dose administration to healthy men.
Busby MG; Jeffcoat AR; Bloedon LT; Koch MA; Black T; Dix KJ; Heizer WD; Thomas BF; Hill JM; Crowell JA; Zeisel SH
Am J Clin Nutr; 2002 Jan; 75(1):126-36. PubMed ID: 11756070
[TBL] [Abstract][Full Text] [Related]
3. Urinary disposition of the soybean isoflavones daidzein, genistein and glycitein differs among humans with moderate fecal isoflavone degradation activity.
Zhang Y; Wang GJ; Song TT; Murphy PA; Hendrich S
J Nutr; 1999 May; 129(5):957-62. PubMed ID: 10222386
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics of isoflavones, daidzein and genistein, after ingestion of soy beverage compared with soy extract capsules in postmenopausal Thai women.
Anupongsanugool E; Teekachunhatean S; Rojanasthien N; Pongsatha S; Sangdee C
BMC Clin Pharmacol; 2005 Mar; 5():2. PubMed ID: 15743537
[TBL] [Abstract][Full Text] [Related]
5. Clinical characteristics and pharmacokinetics of purified soy isoflavones: multiple-dose administration to men with prostate neoplasia.
Fischer L; Mahoney C; Jeffcoat AR; Koch MA; Thomas BE; Valentine JL; Stinchcombe T; Boan J; Crowell JA; Zeisel SH
Nutr Cancer; 2004; 48(2):160-70. PubMed ID: 15231450
[TBL] [Abstract][Full Text] [Related]
6. Bioavailability, disposition, and dose-response effects of soy isoflavones when consumed by healthy women at physiologically typical dietary intakes.
Setchell KD; Brown NM; Desai PB; Zimmer-Nechimias L; Wolfe B; Jakate AS; Creutzinger V; Heubi JE
J Nutr; 2003 Apr; 133(4):1027-35. PubMed ID: 12672914
[TBL] [Abstract][Full Text] [Related]
7. One-month exposure to soy isoflavones did not induce the ability to produce equol in postmenopausal women.
Védrine N; Mathey J; Morand C; Brandolini M; Davicco MJ; Guy L; Rémésy C; Coxam V; Manach C
Eur J Clin Nutr; 2006 Sep; 60(9):1039-45. PubMed ID: 16482068
[TBL] [Abstract][Full Text] [Related]
8. Comparing the pharmacokinetics of daidzein and genistein with the use of 13C-labeled tracers in premenopausal women.
Setchell KD; Faughnan MS; Avades T; Zimmer-Nechemias L; Brown NM; Wolfe BE; Brashear WT; Desai P; Oldfield MF; Botting NP; Cassidy A
Am J Clin Nutr; 2003 Feb; 77(2):411-9. PubMed ID: 12540402
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics of soybean isoflavones in plasma, urine and feces of men after ingestion of 60 g baked soybean powder (kinako).
Watanabe S; Yamaguchi M; Sobue T; Takahashi T; Miura T; Arai Y; Mazur W; Wähälä K; Adlercreutz H
J Nutr; 1998 Oct; 128(10):1710-5. PubMed ID: 9772140
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics of a slow-release formulation of soybean isoflavones in healthy postmenopausal women.
Setchell KD; Brzezinski A; Brown NM; Desai PB; Melhem M; Meredith T; Zimmer-Nechimias L; Wolfe B; Cohen Y; Blatt Y
J Agric Food Chem; 2005 Mar; 53(6):1938-44. PubMed ID: 15769117
[TBL] [Abstract][Full Text] [Related]
11. Impact of equol-producing capacity and soy-isoflavone profiles of supplements on bone calcium retention in postmenopausal women: a randomized crossover trial.
Pawlowski JW; Martin BR; McCabe GP; McCabe L; Jackson GS; Peacock M; Barnes S; Weaver CM
Am J Clin Nutr; 2015 Sep; 102(3):695-703. PubMed ID: 26245807
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics of the glucuronide and sulfate conjugates of genistein and daidzein in men and women after consumption of a soy beverage.
Shelnutt SR; Cimino CO; Wiggins PA; Ronis MJ; Badger TM
Am J Clin Nutr; 2002 Sep; 76(3):588-94. PubMed ID: 12198004
[TBL] [Abstract][Full Text] [Related]
13. Bioavailability of pure isoflavones in healthy humans and analysis of commercial soy isoflavone supplements.
Setchell KD; Brown NM; Desai P; Zimmer-Nechemias L; Wolfe BE; Brashear WT; Kirschner AS; Cassidy A; Heubi JE
J Nutr; 2001 Apr; 131(4 Suppl):1362S-75S. PubMed ID: 11285356
[TBL] [Abstract][Full Text] [Related]
14. Influence of inulin on plasma isoflavone concentrations in healthy postmenopausal women.
Piazza C; Privitera MG; Melilli B; Incognito T; Marano MR; Leggio GM; Roxas MA; Drago F
Am J Clin Nutr; 2007 Sep; 86(3):775-80. PubMed ID: 17823445
[TBL] [Abstract][Full Text] [Related]
15. Plasma and urinary kinetics of the isoflavones daidzein and genistein after a single soy meal in humans.
King RA; Bursill DB
Am J Clin Nutr; 1998 May; 67(5):867-72. PubMed ID: 9583843
[TBL] [Abstract][Full Text] [Related]
16. Daidzein is a more bioavailable soymilk isoflavone than is genistein in adult women.
Xu X; Wang HJ; Murphy PA; Cook L; Hendrich S
J Nutr; 1994 Jun; 124(6):825-32. PubMed ID: 8207540
[TBL] [Abstract][Full Text] [Related]
17. Hydrolysis of isoflavone glycosides to aglycones by beta-glycosidase does not alter plasma and urine isoflavone pharmacokinetics in postmenopausal women.
Richelle M; Pridmore-Merten S; Bodenstab S; Enslen M; Offord EA
J Nutr; 2002 Sep; 132(9):2587-92. PubMed ID: 12221213
[TBL] [Abstract][Full Text] [Related]
18. Phase I pharmacokinetic and pharmacodynamic analysis of unconjugated soy isoflavones administered to individuals with cancer.
Takimoto CH; Glover K; Huang X; Hayes SA; Gallot L; Quinn M; Jovanovic BD; Shapiro A; Hernandez L; Goetz A; Llorens V; Lieberman R; Crowell JA; Poisson BA; Bergan RC
Cancer Epidemiol Biomarkers Prev; 2003 Nov; 12(11 Pt 1):1213-21. PubMed ID: 14652284
[TBL] [Abstract][Full Text] [Related]
19. Lack of significant genotoxicity of purified soy isoflavones (genistein, daidzein, and glycitein) in 20 patients with prostate cancer.
Miltyk W; Craciunescu CN; Fischer L; Jeffcoat RA; Koch MA; Lopaczynski W; Mahoney C; Jeffcoat RA; Crowell J; Paglieri J; Zeisel SH
Am J Clin Nutr; 2003 Apr; 77(4):875-82. PubMed ID: 12663286
[TBL] [Abstract][Full Text] [Related]
20. Serum levels and metabolic clearance of the isoflavones genistein and daidzein in hemodialysis patients.
Fanti P; Sawaya BP; Custer LJ; Franke AA
J Am Soc Nephrol; 1999 Apr; 10(4):864-71. PubMed ID: 10203372
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
